The caf & eacute; prot & egrave ; he ge against the scl & eacute; Sclerosis ?
The researchers analyzed & eacute; a dé study su & eacute; doise men & eacute; e on 1629 people with scl & eacute; Sclerosis and 2807 healthy subjects, as well as research am dé Rican conducted on 1159 people with the disease and 1,172 others healthy people & eacute;.
They noted & eacute; coffee consumption habits & eacute; participants am & eacute; Ricans with scl & eacute; Sclerosis one & agrave ; five years before the onset of symptoms & OCIRC ; and my up & agrave ; ten years before in the dé study su & eacute; doise.
Researchers have the compar & eacute; es with the consumption of coffee & eacute; ine participants in good health & eacute; for p & eacute; similar periods.
Researchers & eacute; also taken into account other factors such as & acirc ; age, sex, smoking, body mass index and sun exposure habits.
In su & eacute group have, those who drank no coffee & eacute; were 1.5 times more likely to dé velop the disease than those who were taking at least 6 cups daily.
Drinking large quantities & eacute ; s caf & eacute; 5 or 10 years before the onset of symptoms & OCIRC ; my poss & egrave ; of & eacute; also a protective effect.
In the & eacute; tude am dé -American, people do not drink coffee & eacute; & eacute; were & eacute; also about one and a half times more likely to dé velop the disease than those who drank four or more cups of coffee & eacute; a day in ann & eacute; e pr & eacute; c & eacute; ing the onset of symptoms & OCIRC ; my.
& quot; coffee consumption & eacute; ine d & eacute; j & agrave ; & eacute; t & eacute; li & eacute; e & agrave ; a r & eacute; reduction in the risk of Parkinson’s disease and Alzheimer’s, and our dé study shows that it also has potential protective effects against the scl & eacute; Sclerosis & quot ;, said Dr. Ellen Mowry, a neurologist and professor & agrave ; the university & eacute; Johns Hopkins in Baltimore.
This & quot; Conforte id & eacute; e that this substance may have effects b & eacute; n & eacute; cific for the brain & quot ;, has she added & eacute;.
& quot; The caf & eacute; ine should be the subject of research on its impact on relapses and disability in the scl & eacute; Sclerosis & quot;.
MS, a neurological disease & agrave ; pr & eacute; dominance f & eacute; minine.
The scl & eacute; Sclerosis is a chronic autoimmune disease of the neurological system & egrave ; central nervous.
Its d & eacute; t & eacute; deterioration causes disruption sent é information; es from the brain to the body, entered & icirc ; ing & agrave ; long-term disability heavier or lighter.
MS has a net pr & eacute; f & eacute; rence for young women between 20 and 40 years.
This is the first & egrave ; re cause of acquired neurological disability in young adults in France.
These r & eacute; results will be a pr & eacute; Presentation & agrave ; conf & eacute; Annual Conference of the Acad & eacute; mie am dé Neurology Rican to be held & agrave ; Washington from 18 to 25 April.